Skip to main content
BJDXHealthcare

Bluejay Diagnostics Inc (BJDX) Insider Trading

In the last 90 days, no Bluejay Diagnostics Inc (BJDX) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 10, 2026Hrt Financial LPCorporate insiderSale98,985$1.47$145,627
Mar 14, 2026Douglas Clark WurthCorporate insiderOpen Market Purchase12,500$2.00$25,000
Mar 14, 2026Indranil DeyPresident and CEOOpen Market Purchase12,500$2.00$25,000
Mar 14, 2026Donald R ChaseCorporate insiderOpen Market Purchase12,500$2.00$25,000
Mar 14, 2026Fred S ZeidmanCorporate insiderOpen Market Purchase12,500$2.00$25,000
Mar 14, 2026Svetlana DeyCorporate insiderOpen Market Purchase12,500$2.00$25,000

Common questions

BJDX insider trading FAQ

Are BJDX insiders buying or selling?
No BJDX insiders reported open-market purchases or sales in the last 90 days.
When was the last BJDX insider purchase?
No open-market insider purchase of Bluejay Diagnostics Inc stock was reported in the last 90 days.
Where does BJDX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Bluejay Diagnostics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.